Literature DB >> 32228356

Heat shock proteins as biomarkers of lung cancer.

Sonam Mittal1, Maitreyi S Rajala1.   

Abstract

Heat shock proteins are known to be associated with a wide variety of human cancers including lung cancer. Overexpression of these molecular chaperones is linked with tumor survival, metastasis and anticancer drug resistance. In recent years, heat shock proteins are gaining much importance in the field of cancer research owing to their potential to be key determinants of cell survival and apoptosis. Lung cancer is one of the most common cancers diagnosed worldwide and the association of heat shock proteins in lung cancer diagnosis, prognosis and as drug targets remains unresolved. The aim of this review is to draw the importance of heat shock protein members; Hsp27, Hsp70, Hsp90, Hsp60 and their diagnostic and prognostic implications in lung cancer. Based on the available literature heat shock proteins can serve as biomarkers and anticancer drug targets in the management of lung cancer patients.

Entities:  

Keywords:  EGFR; HSP; NSCLC; biomarker; diagnosis; immunotherapy; prognosis

Year:  2020        PMID: 32228356      PMCID: PMC7515496          DOI: 10.1080/15384047.2020.1736482

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  80 in total

1.  Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27.

Authors:  Han-Shui Hsu; Jiun-Han Lin; Wen-Chien Huang; Tien-Wei Hsu; Kelly Su; Shih-Hwa Chiou; Yo-Ting Tsai; Shih-Chieh Hung
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

2.  Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism.

Authors:  Andrea Havasi; Zhijian Li; Zhiyong Wang; Jody L Martin; Venugopal Botla; Kathleen Ruchalski; John H Schwartz; Steven C Borkan
Journal:  J Biol Chem       Date:  2008-02-25       Impact factor: 5.157

Review 3.  HSP90 and the chaperoning of cancer.

Authors:  Luke Whitesell; Susan L Lindquist
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

4.  HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.

Authors:  Ting Xu; Qingyi Wei; Jose Luis Lopez Guerra; Li-E Wang; Zhensheng Liu; Daniel Gomez; Michael O'Reilly; Steven Hsesheng Lin; Yan Zhuang; Lawrence B Levy; Radhe Mohan; Honghao Zhou; Zhongxing Liao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-19       Impact factor: 7.038

Review 5.  Heat Shock Proteins Promote Cancer: It's a Protection Racket.

Authors:  Stuart K Calderwood; Jianlin Gong
Journal:  Trends Biochem Sci       Date:  2016-02-11       Impact factor: 13.807

6.  IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo.

Authors:  Mariko Oba; Shuichiro Yano; Tsuyoshi Shuto; Mary Ann Suico; Ayaka Eguma; Hirofumi Kai
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

Review 7.  Heat shock transcription factors: structure and regulation.

Authors:  C Wu
Journal:  Annu Rev Cell Dev Biol       Date:  1995       Impact factor: 13.827

8.  Distinct prognostic roles of HSPB1 expression in non-small cell lung cancer.

Authors:  Z C Huang; H Li; Z Q Sun; J Zheng; R K Zhao; J Chen; S G Sun; C J Wu
Journal:  Neoplasma       Date:  2018       Impact factor: 2.575

9.  Wild-type EGFR is stabilized by direct interaction with HSP90 in cancer cells and tumors.

Authors:  Aarif Ahsan; Susmita G Ramanand; Christopher Whitehead; Susan M Hiniker; Alnawaz Rehemtulla; William B Pratt; Shruti Jolly; Christopher Gouveia; Kristy Truong; Carter Van Waes; Dipankar Ray; Theodore S Lawrence; Mukesh K Nyati
Journal:  Neoplasia       Date:  2012-08       Impact factor: 5.715

10.  Ibuprofen enhances the anticancer activity of cisplatin in lung cancer cells by inhibiting the heat shock protein 70.

Authors:  H Endo; M Yano; Y Okumura; H Kido
Journal:  Cell Death Dis       Date:  2014-01-30       Impact factor: 8.469

View more
  10 in total

1.  The therapeutic potential of attenuated diphtheria toxin delivered by an adenovirus vector with survivin promoter on human lung cancer cells.

Authors:  Lvxia Dai; Xiaoping Yu; Sizhou Huang; Yanjuan Peng; Jianmin Liu; Tian Chen; Xin Wang; Qiaofeng Liu; Yanfeng Zhu; Dengbang Chen; Xiaohua Li; Yu Ou; Yi Zou; Qu Pan; Kang Cao
Journal:  Cancer Biol Ther       Date:  2020-12-30       Impact factor: 4.742

2.  Variations of human heat shock proteins in multiple cancers.

Authors:  Xiaoxia Liu; Ka Li; Lingyan Wang; Miaomiao Zhang; Xiangdong Wang
Journal:  Clin Transl Med       Date:  2021-02

3.  Plasma Heat Shock Protein 90 Alpha: A Valuable Predictor of Early Chemotherapy Effectiveness in Advanced Non-Small-Cell Lung Cancer.

Authors:  Bo Zhong; Juxin Shen; Chunyi Zhang; Guozhong Zhou; Yuefang Yu; E Qin; Jixian Tang; Dongping Wu; Xiaochao Liang
Journal:  Med Sci Monit       Date:  2021-01-09

Review 4.  Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review).

Authors:  Yongqin Zeng; Xiuzhi Lv; Juan Du
Journal:  Oncol Rep       Date:  2021-09-09       Impact factor: 3.906

Review 5.  HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis.

Authors:  Zarema Albakova; Yana Mangasarova; Akhmet Albakov; Liliya Gorenkova
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

Review 6.  Host cell stress response as a predictor of COVID-19 infectivity and disease progression.

Authors:  Celine Caillet; Melissa Louise Stofberg; Victor Muleya; Addmore Shonhai; Tawanda Zininga
Journal:  Front Mol Biosci       Date:  2022-08-11

7.  Theileria annulata SVSP455 interacts with host HSP60.

Authors:  Zhi Li; Junlong Liu; Shuaiyang Zhao; Quanying Ma; Zhihong Guo; Aihong Liu; Youquan Li; Guiquan Guan; Jianxun Luo; Hong Yin
Journal:  Parasit Vectors       Date:  2022-08-30       Impact factor: 4.047

8.  Circadian disruption enhances HSF1 signaling and tumorigenesis in Kras-driven lung cancer.

Authors:  Marie Pariollaud; Lara H Ibrahim; Emanuel Irizarry; Rebecca M Mello; Alanna B Chan; Brian J Altman; Reuben J Shaw; Michael J Bollong; R Luke Wiseman; Katja A Lamia
Journal:  Sci Adv       Date:  2022-09-28       Impact factor: 14.957

Review 9.  Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer.

Authors:  Weronika Ratajczak; Michał Lubkowski; Anna Lubkowska
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

10.  Performance of Plasma HSP90α, Serum EBV VCA IgA Antibody and Plasma EBV DNA for the Diagnosis and Prognosis Prediction of Nasopharyngeal Carcinoma.

Authors:  Qian Ye; Junying Guo; Yansong Chen; Zhaolei Cui; Yan Chen
Journal:  Cancer Manag Res       Date:  2021-07-20       Impact factor: 3.989

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.